Compare $BAX vs $GEHC | Chartloom

Compare

$BAX vs $GEHC

Baxter International Inc · GE Healthcare Technologies Inc

BAX

Baxter International Inc

GEHC

GE Healthcare Technologies Inc

Compare $BAX vs $GEHC

Comparing Baxter International Inc and GE Healthcare Technologies Inc

BAXBaxter International Inc

GEHCGE Healthcare Technologies Inc

BAXBaxter International Inc

Market cap

$12.58B

P/E (TTM)

—

Forward P/E (NTM)

11.35x

Forward P/S (NTM)

1.06x

Rev growth (TTM)

5.4%

YTD performance

24.9%

52W performance

7.0%

FCF yield

6.5%

GEHCGE Healthcare Technologies Inc

Market cap

$29.69B

P/E (TTM)

15.04x

Forward P/E (NTM)

12.46x

Forward P/S (NTM)

1.31x

Rev growth (TTM)

6.5%

YTD performance

-20.6%

52W performance

-12.5%

FCF yield

5.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BAX

GEHC

Detailed metrics comparison

BAX

Baxter International Inc

GEHC

GE Healthcare Technologies Inc

Market Cap

BAX$12.58B

GEHC$29.69B

Enterprise Value

BAX$19.89B

GEHC$37.76B

Price

BAX$24.35

GEHC$65.74

P/E Ratio

BAXN/A

GEHC15.04x

P/S Ratio

BAX1.10x

GEHC1.40x

EV/Sales

BAX1.73x

GEHC1.78x

EV/EBITDA

BAX13.60x

GEHC11.19x

P/B Ratio

BAX1.96x

GEHC2.65x

P/FCF Ratio

BAX15.43x

GEHC18.81x

EV/FCF

BAX24.40x

GEHC23.92x

PEG Ratio

BAXN/A

GEHC2.18x

Forward P/E (NTM)

BAX11.35x

GEHC12.46x

Forward P/S (NTM)

BAX1.06x

GEHC1.31x

Revenue (TTM)

BAX$11.47B

GEHC$21.27B

Revenue Growth (YoY)

BAX5.4%

GEHC6.5%

Forward Rev Growth

BAX2.1%

GEHC4.6%

Gross Margin (TTM)

BAX30.7%

GEHC39.5%

Operating Margin (TTM)

BAX0.0%

GEHC12.9%

EBITDA Margin (TTM)

BAX12.7%

GEHC15.7%

Net Margin (TTM)

BAX-9.3%

GEHC9.3%

FCF Margin (TTM)

BAX7.1%

GEHC7.4%

Net Income (TTM)

BAX$-1.06B

GEHC$1.99B

FCF (TTM)

BAX$815M

GEHC$1.58B

EPS (TTM)

BAX-$2.05

GEHC$4.37

ROE (TTM)

BAX-1660.0%

GEHC18.9%

ROA (TTM)

BAX-527.0%

GEHC5.4%

ROIC (TTM)

BAX-669.0%

GEHC9.6%

Cash

BAX$2.15B

GEHC$2.08B

Debt

BAX$9.46B

GEHC$10.15B

Net Cash/Debt

BAX$-7.31B

GEHC$-8.07B

Current Ratio (TTM)

BAX1.95x

GEHC1.26x

Quick Ratio (TTM)

BAX1.15x

GEHC0.93x

Debt/Equity (TTM)

BAX1.52x

GEHC0.92x

Debt/Assets (TTM)

BAX0.0%

GEHC0.0%

Interest Coverage (TTM)

BAXN/A

GEHCN/A

Net Debt/EBITDA (TTM)

BAX0.00x

GEHC0.00x

Beta

BAX0.67

GEHC0.85

52W Performance

BAX7.0%

GEHC-12.5%

YTD Performance

BAX24.9%

GEHC-20.6%

% from 52W High

BAX-18.8%

GEHC-26.8%

% from 52W Low

BAX54.8%

GEHC11.9%

Asset Turnover (TTM)

BAX0.57x

GEHC0.58x

FCF Yield (TTM)

BAX6.5%

GEHC5.3%

Earnings Yield (TTM)

BAX-8.5%

GEHC6.7%

Dividend Yield (TTM)

BAX1.5%

GEHC0.2%

Rule of 40

BAX12.5

GEHC13.9

EV/GP/RG

BAX1.72

GEHC0.71

Ticker research

View BAX research View GEHC research

Metric	BAX Baxter International Inc	GEHC GE Healthcare Technologies Inc
Market & Valuation
Market Cap	$12.58B	$29.69B
Enterprise Value	$19.89B	$37.76B
Price	$24.35	$65.74
P/E Ratio	N/A	15.04x
P/S Ratio	1.10x	1.40x
EV/Sales	1.73x	1.78x
EV/EBITDA	13.60x	11.19x
P/B Ratio	1.96x	2.65x
P/FCF Ratio	15.43x	18.81x
EV/FCF	24.40x	23.92x
PEG Ratio	N/A	2.18x
Forward P/E (NTM)	11.35x	12.46x
Forward P/S (NTM)	1.06x	1.31x
Revenue & Growth
Revenue (TTM)	$11.47B	$21.27B
Revenue Growth (YoY)	5.4%	6.5%
Forward Rev Growth	2.1%	4.6%
Profitability
Gross Margin (TTM)	30.7%	39.5%
Operating Margin (TTM)	0.0%	12.9%
EBITDA Margin (TTM)	12.7%	15.7%
Net Margin (TTM)	-9.3%	9.3%
FCF Margin (TTM)	7.1%	7.4%
Net Income (TTM)	$-1.06B	$1.99B
FCF (TTM)	$815M	$1.58B
EPS (TTM)	-$2.05	$4.37
ROE (TTM)	-1660.0%	18.9%
ROA (TTM)	-527.0%	5.4%
ROIC (TTM)	-669.0%	9.6%
Financial Health
Cash	$2.15B	$2.08B
Debt	$9.46B	$10.15B
Net Cash/Debt	$-7.31B	$-8.07B
Current Ratio (TTM)	1.95x	1.26x
Quick Ratio (TTM)	1.15x	0.93x
Debt/Equity (TTM)	1.52x	0.92x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.67	0.85
52W Performance	7.0%	-12.5%
YTD Performance	24.9%	-20.6%
% from 52W High	-18.8%	-26.8%
% from 52W Low	54.8%	11.9%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.58x
FCF Yield (TTM)	6.5%	5.3%
Earnings Yield (TTM)	-8.5%	6.7%
Dividend Yield (TTM)	1.5%	0.2%
Other
Rule of 40	12.5	13.9
EV/GP/RG	1.72	0.71
Ticker research	View BAX research	View GEHC research

Valuation

P/E Ratio

GEHC

15.04x

P/S Ratio

BAX

1.10x

GEHC

1.40x

EV/FCF

GEHC

23.92x

BAX

24.40x

Growth & revenue

Revenue Growth TTM

GEHC

6.5%

BAX

5.4%

Forward Revenue Growth

GEHC

4.6%

BAX

2.1%

Profitability & performance

Gross Margin

GEHC

39.5%

BAX

30.7%

ROE

GEHC

18.9%

BAX

-1660.0%

FCF Yield %

BAX

6.5%

GEHC

5.3%

52-Week Performance

BAX

7.0%

GEHC

-12.5%

Detailed metrics comparison

BAX

Baxter International Inc

GEHC

GE Healthcare Technologies Inc

Market Cap

BAX$12.58B

GEHC$29.69B

Enterprise Value

BAX$19.89B

GEHC$37.76B

Price

BAX$24.35

GEHC$65.74

P/E Ratio

BAXN/A

GEHC15.04x

P/S Ratio

BAX1.10x

GEHC1.40x

EV/Sales

BAX1.73x

GEHC1.78x

EV/EBITDA

BAX13.60x

GEHC11.19x

P/B Ratio

BAX1.96x

GEHC2.65x

P/FCF Ratio

BAX15.43x

GEHC18.81x

EV/FCF

BAX24.40x

GEHC23.92x

PEG Ratio

BAXN/A

GEHC2.18x

Forward P/E (NTM)

BAX11.35x

GEHC12.46x

Forward P/S (NTM)

BAX1.06x

GEHC1.31x

Revenue (TTM)

BAX$11.47B

GEHC$21.27B

Revenue Growth (YoY)

BAX5.4%

GEHC6.5%

Forward Rev Growth

BAX2.1%

GEHC4.6%

Gross Margin (TTM)

BAX30.7%

GEHC39.5%

Operating Margin (TTM)

BAX0.0%

GEHC12.9%

EBITDA Margin (TTM)

BAX12.7%

GEHC15.7%

Net Margin (TTM)

BAX-9.3%

GEHC9.3%

FCF Margin (TTM)

BAX7.1%

GEHC7.4%

Net Income (TTM)

BAX$-1.06B

GEHC$1.99B

FCF (TTM)

BAX$815M

GEHC$1.58B

EPS (TTM)

BAX-$2.05

GEHC$4.37

ROE (TTM)

BAX-1660.0%

GEHC18.9%

ROA (TTM)

BAX-527.0%

GEHC5.4%

ROIC (TTM)

BAX-669.0%

GEHC9.6%

Cash

BAX$2.15B

GEHC$2.08B

Debt

BAX$9.46B

GEHC$10.15B

Net Cash/Debt

BAX$-7.31B

GEHC$-8.07B

Current Ratio (TTM)

BAX1.95x

GEHC1.26x

Quick Ratio (TTM)

BAX1.15x

GEHC0.93x

Debt/Equity (TTM)

BAX1.52x

GEHC0.92x

Debt/Assets (TTM)

BAX0.0%

GEHC0.0%

Interest Coverage (TTM)

BAXN/A

GEHCN/A

Net Debt/EBITDA (TTM)

BAX0.00x

GEHC0.00x

Beta

BAX0.67

GEHC0.85

52W Performance

BAX7.0%

GEHC-12.5%

YTD Performance

BAX24.9%

GEHC-20.6%

% from 52W High

BAX-18.8%

GEHC-26.8%

% from 52W Low

BAX54.8%

GEHC11.9%

Asset Turnover (TTM)

BAX0.57x

GEHC0.58x

FCF Yield (TTM)

BAX6.5%

GEHC5.3%

Earnings Yield (TTM)

BAX-8.5%

GEHC6.7%

Dividend Yield (TTM)

BAX1.5%

GEHC0.2%

Rule of 40

BAX12.5

GEHC13.9

EV/GP/RG

BAX1.72

GEHC0.71

Ticker research

View BAX research View GEHC research

Metric	BAX Baxter International Inc	GEHC GE Healthcare Technologies Inc
Market & Valuation
Market Cap	$12.58B	$29.69B
Enterprise Value	$19.89B	$37.76B
Price	$24.35	$65.74
P/E Ratio	N/A	15.04x
P/S Ratio	1.10x	1.40x
EV/Sales	1.73x	1.78x
EV/EBITDA	13.60x	11.19x
P/B Ratio	1.96x	2.65x
P/FCF Ratio	15.43x	18.81x
EV/FCF	24.40x	23.92x
PEG Ratio	N/A	2.18x
Forward P/E (NTM)	11.35x	12.46x
Forward P/S (NTM)	1.06x	1.31x
Revenue & Growth
Revenue (TTM)	$11.47B	$21.27B
Revenue Growth (YoY)	5.4%	6.5%
Forward Rev Growth	2.1%	4.6%
Profitability
Gross Margin (TTM)	30.7%	39.5%
Operating Margin (TTM)	0.0%	12.9%
EBITDA Margin (TTM)	12.7%	15.7%
Net Margin (TTM)	-9.3%	9.3%
FCF Margin (TTM)	7.1%	7.4%
Net Income (TTM)	$-1.06B	$1.99B
FCF (TTM)	$815M	$1.58B
EPS (TTM)	-$2.05	$4.37
ROE (TTM)	-1660.0%	18.9%
ROA (TTM)	-527.0%	5.4%
ROIC (TTM)	-669.0%	9.6%
Financial Health
Cash	$2.15B	$2.08B
Debt	$9.46B	$10.15B
Net Cash/Debt	$-7.31B	$-8.07B
Current Ratio (TTM)	1.95x	1.26x
Quick Ratio (TTM)	1.15x	0.93x
Debt/Equity (TTM)	1.52x	0.92x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.67	0.85
52W Performance	7.0%	-12.5%
YTD Performance	24.9%	-20.6%
% from 52W High	-18.8%	-26.8%
% from 52W Low	54.8%	11.9%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.58x
FCF Yield (TTM)	6.5%	5.3%
Earnings Yield (TTM)	-8.5%	6.7%
Dividend Yield (TTM)	1.5%	0.2%
Other
Rule of 40	12.5	13.9
EV/GP/RG	1.72	0.71
Ticker research	View BAX research	View GEHC research